Gen Cap America has sold Avanti Products to The Legacy Companies
Lincoln acted as the exclusive financial advisor to Gen Cap and Avanti, working closely with the Gen Cap and the Avanti management teams throughout the sale process. The Lincoln team provided M&A and industry expertise, as well as closely managing all aspects of the process, including the preparatory, marketing, negotiation and due diligence phases of the transaction.
“Lincoln was a valued partner throughout the transaction. Lincoln worked hand-in-hand with us from start to finish creating a number of compelling options for the company’s shareholders,” Matt Lane, Managing Director and deal lead at Gen Cap commented. Richard Ladd, Avanti’s CEO, added “We are excited that Lincoln helped us find the right partner at this exciting time in our industry, and we are thrilled to join with Legacy as we embark on the next phase of our growth.”
Based in Miami, Florida, Avanti is a leader in the space-saving and specialty consumer appliance industry, specializing in refrigeration, cooking, wine chiller and laundry & dishwasher products and other specialty appliances. Avanti is highly regarded for its strong reputation in design, sourcing and distribution, serving a diverse customer base of retailers, wholesalers and distributors through its efficient inventory management and differentiated aftermarket support services. For more information, please visit www.avantiproducts.com.
Meet our Senior Team
View More Transactions
Lincoln International is pleased to announce the successful sale of C³ (Cannabinoid Compound Company), a subsidiary of Bionorica SE, a producer and marketer of cannabis-based therapeutic compounds, to Canopy Growth
Lincoln is pleased to announce that it has advised Riello Investimenti SGR on the sale of Trafimet Group to Kemppi Oy
Lincoln International is pleased to have advised Tikehau Capital on its £23 million minority investment into Medtrade, a UK based manufacturer of advanced woundcare and consumer healthcare products
Lincoln International is pleased to announce the successful completion of a $20 million Series C financing round for Rapid Medical